Showing results (421-430 of 516) with videos related to

Sort By:
Pageof 52
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspectiveMaria Luisa Garrè, Armando Cama, Francesca Bagnasco, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2021
Telomerase reverse transcriptase promoter mutation- and O6-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
In Vivo (Athens, Greece)|October 30, 2025
Improved Implementation of Tumor Board Decisions: A Retrospective Single Center Observational Study in GermanyJohanna Ernst, Katharina Alfter, Alexander Mustea, et al.
Neuro-Oncology Advances|May 18, 2026
A methylome-based score to predict survival after regorafenib in recurrent glioblastomaSilvia Chiesa, Evelina Miele, Sara Patrizi, et al.
RMD Open|February 13, 2024
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammationLavinia Agra Coletto, Valentina Marino, Chiara Rizzo, et al.
Acta Neuropathologica|September 8, 2021
Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomasElmar Kirches, Felix Sahm, Andrey Korshunov, et al.
Biomarker Research|June 17, 2022
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progressionGiuseppina Catanzaro, Zein Mersini Besharat, Andrea Carai, et al.
Neuro-Oncology|December 17, 2020
Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 studyJonas E Adolph, Gudrun Fleischhack, Ruth Mikasch, et al.
Biomedicines|January 25, 2025
MicroRNAs Expression Profile in MN1-Altered AstroblastomaFrancesca Gianno, Evelina Miele, Claudia Sabato, et al.
Acta Neuropathologica|April 4, 2023
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratificationJack Goddard, Jemma Castle, Emily Southworth, et al.
Pageof 52